Our newly identified RNASEH1‐AS1/miR‐516a‐5p/FOXK1/Wnt/β‐catenin network may offer an interesting foundation for NSCLC treatment in the clinic. The gene discussed is FOXK1; the disease is non-small cell lung carcinoma.